Skip to main content
logo
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.710
-0.030 (-0.80%)
Jul 31, 2026, 3:59 PM HKT

HKG:6922 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
95.2795.2753.5340.9527.1522.43
Revenue Growth
11.87%77.97%30.72%50.83%21.06%147.69%
Gross Profit
63.9863.9838.4131.0519.3615.55
Operating Income
-43.43-43.43-130.33-119.77-128.9-78.87
Net Income
-38.17-38.17-104.37-97.49-112.22-101.87
Earnings Per Share
-0.16-0.16-0.44-0.41-0.49-0.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35.7135.7146.26104.46228.34159.3
Total Debt
26.226.243.3211.0111.379
Net Cash (Debt)
9.519.512.9493.44216.97150.3
Net Cash Growth
-62.78%223.44%-96.86%-56.93%44.36%360.28%
Net Cash Per Share
0.040.040.010.390.950.66

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.82-5.82-82.91-95.89-96.94-62.49
Capital Expenditures
-0.77-0.77-1.88-15.1-7.01-12.44
Free Cash Flow
-6.59-6.59-84.79-111-103.95-74.93
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.16%67.16%71.75%75.83%71.32%69.32%
Operating Margin
-45.59%-45.59%-243.46%-292.48%-474.77%-351.68%
Pretax Margin
-46.66%-46.66%-207.62%-258.23%-435.80%-564.06%
Profit Margin
-40.06%-40.06%-194.96%-238.06%-413.36%-454.26%
FCF Margin
-6.92%-6.92%-158.39%-271.05%-382.87%-334.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.5615.5234.2599.75137.58-